Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Higher circulating bile acid concentrations in obese patients with type 2 diabetes.

Vincent RP, Omar S, Ghozlan S, Taylor DR, Cross G, Sherwood RA, Fandriks L, Olbers T, Werling M, Alaghband-Zadeh J, le Roux CW.

Ann Clin Biochem. 2013 Jul;50(Pt 4):360-4. doi: 10.1177/0004563212473450. Epub 2013 Jun 14.

PMID:
23771134
2.

Enhanced fasting and post-prandial plasma bile acid responses after Roux-en-Y gastric bypass surgery.

Werling M, Vincent RP, Cross GF, Marschall HU, Fändriks L, Lönroth H, Taylor DR, Alaghband-Zadeh J, Olbers T, Le Roux CW.

Scand J Gastroenterol. 2013 Nov;48(11):1257-64. doi: 10.3109/00365521.2013.833647. Epub 2013 Sep 18.

PMID:
24044585
3.

Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism.

Patti ME, Houten SM, Bianco AC, Bernier R, Larsen PR, Holst JJ, Badman MK, Maratos-Flier E, Mun EC, Pihlajamaki J, Auwerx J, Goldfine AB.

Obesity (Silver Spring). 2009 Sep;17(9):1671-7. doi: 10.1038/oby.2009.102. Epub 2009 Apr 9.

4.

Fasting serum taurine-conjugated bile acids are elevated in type 2 diabetes and do not change with intensification of insulin.

Wewalka M, Patti ME, Barbato C, Houten SM, Goldfine AB.

J Clin Endocrinol Metab. 2014 Apr;99(4):1442-51. doi: 10.1210/jc.2013-3367. Epub 2014 Jan 16.

PMID:
24432996
5.

Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study.

Beysen C, Murphy EJ, Deines K, Chan M, Tsang E, Glass A, Turner SM, Protasio J, Riiff T, Hellerstein MK.

Diabetologia. 2012 Feb;55(2):432-42. doi: 10.1007/s00125-011-2382-3. Epub 2011 Dec 2.

PMID:
22134839
6.

Correlation between postprandial bile acids and body fat mass in healthy normal-weight subjects.

Suzuki T, Aoyama J, Hashimoto M, Ohara M, Futami-Suda S, Suzuki K, Ouchi M, Igari Y, Watanabe K, Nakano H.

Clin Biochem. 2014 Aug;47(12):1128-31. doi: 10.1016/j.clinbiochem.2014.04.025. Epub 2014 May 2.

PMID:
24794786
7.

Postprandial hyperlipidemia after a fat loading test in minority adolescents with type 2 diabetes mellitus and obesity.

Umpaichitra V, Banerji MA, Castells S.

J Pediatr Endocrinol Metab. 2004 Jun;17(6):853-64.

PMID:
15270403
8.

Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.

Knop FK, Aaboe K, Vilsbøll T, Vølund A, Holst JJ, Krarup T, Madsbad S.

Diabetes Obes Metab. 2012 Jun;14(6):500-10. doi: 10.1111/j.1463-1326.2011.01549.x. Epub 2012 Jan 17.

PMID:
22171657
9.

Postprandial paradoxical IGFBP-1 response in obese patients with Type 2 diabetes.

Lehtihet M, Efendic S, Brismar K.

Clin Sci (Lond). 2008 Sep;115(5):167-74. doi: 10.1042/CS20070372.

PMID:
18208402
11.

Improved glycemic control with colesevelam treatment in patients with type 2 diabetes is not directly associated with changes in bile acid metabolism.

Brufau G, Stellaard F, Prado K, Bloks VW, Jonkers E, Boverhof R, Kuipers F, Murphy EJ.

Hepatology. 2010 Oct;52(4):1455-64. doi: 10.1002/hep.23831.

PMID:
20725912
12.

[The features of postprandial glucose state in type 2 diabetes mellitus].

Zhou J, Jia WP, Yu M, Ma XJ, Bao YQ, Lu W.

Zhonghua Yi Xue Za Zhi. 2006 Apr 11;86(14):970-5. Chinese.

PMID:
16759538
13.

Bedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes.

Juhl CB, Hollingdal M, Sturis J, Jakobsen G, Agersø H, Veldhuis J, Pørksen N, Schmitz O.

Diabetes. 2002 Feb;51(2):424-9.

14.

Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients.

Sonne DP, Hare KJ, Martens P, Rehfeld JF, Holst JJ, Vilsbøll T, Knop FK.

Am J Physiol Gastrointest Liver Physiol. 2013 Feb 15;304(4):G413-9. doi: 10.1152/ajpgi.00435.2012. Epub 2012 Dec 28.

15.

Temporal changes in bile acid levels and 12α-hydroxylation after Roux-en-Y gastric bypass surgery in type 2 diabetes.

Dutia R, Embrey M, O'Brien CS, Haeusler RA, Agénor KK, Homel P, McGinty J, Vincent RP, Alaghband-Zadeh J, Staels B, le Roux CW, Yu J, Laferrère B.

Int J Obes (Lond). 2015 May;39(5):806-13. doi: 10.1038/ijo.2015.1. Epub 2015 Jan 20. Erratum in: Int J Obes (Lond). 2016 Mar;40(3):554. O'Brien, S [corrected to O'Brien, C S].

16.

Postprandial total and HMW adiponectin following a high-fat meal in lean, obese and diabetic men.

Phillips LK, Peake JM, Zhang X, Hickman IJ, Briskey DR, Huang BE, Simpson P, Li SH, Whitehead JP, Martin JH, Prins JB.

Eur J Clin Nutr. 2013 Apr;67(4):377-84. doi: 10.1038/ejcn.2013.49. Epub 2013 Mar 6.

PMID:
23462948
17.

Bile-induced secretion of glucagon-like peptide-1: pathophysiological implications in type 2 diabetes?

Knop FK.

Am J Physiol Endocrinol Metab. 2010 Jul;299(1):E10-3. doi: 10.1152/ajpendo.00137.2010. Epub 2010 Apr 27. Review.

18.

Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.

Henkel E, Menschikowski M, Koehler C, Leonhardt W, Hanefeld M.

Metabolism. 2005 Sep;54(9):1168-73.

PMID:
16125528
19.

Is postprandial hypertriglyceridaemia in relatives of type 2 diabetic subjects a consequence of insulin resistance?

Kriketos A, Milner KL, Denyer G, Campbell L.

Eur J Clin Invest. 2005 Feb;35(2):117-25.

PMID:
15667583

Supplemental Content

Support Center